Dorsey & Whitney Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Dorsey & Whitney Trust's BIIB Position: Q2 2026 in Review
Dorsey & Whitney Trust increased its Biogen (BIIB) stake by 0.19% in Q2 2026, buying an estimated $574 and bringing the position to 1,549 shares worth $335K. The position accounts for 0.02% of the portfolio, ranked #554.
Dorsey & Whitney Trust first reported a position in BIIB in Q2 2013 and has held it in 19 quarters since. The position peaked at $574K in Q1 2015. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Dorsey & Whitney Trust held 1,549 shares of Biogen worth $335K as of Q2 2026.
- Dorsey & Whitney Trust bought 3 Biogen shares in Q2 2026, an estimated $574.
- Biogen made up 0.02% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #554 holding.
- Dorsey & Whitney Trust first reported a position in Biogen in Q2 2013 and has held it in 19 quarters since.
- Dorsey & Whitney Trust's Biogen position peaked at $574K in Q1 2015.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.